AU2016309397B2 - Mussel adhesive protein product and application thereof in inhibiting catarrh - Google Patents

Mussel adhesive protein product and application thereof in inhibiting catarrh Download PDF

Info

Publication number
AU2016309397B2
AU2016309397B2 AU2016309397A AU2016309397A AU2016309397B2 AU 2016309397 B2 AU2016309397 B2 AU 2016309397B2 AU 2016309397 A AU2016309397 A AU 2016309397A AU 2016309397 A AU2016309397 A AU 2016309397A AU 2016309397 B2 AU2016309397 B2 AU 2016309397B2
Authority
AU
Australia
Prior art keywords
map
mefp
cancer
patients
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016309397A
Other languages
English (en)
Other versions
AU2016309397A1 (en
Inventor
Min Gao
Bengt Ingemar Samuelsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangyin Bengt I Samuelsson Institute Of Life Science Co Ltd
Original Assignee
Jiangyin Bengt I Samuelsson Institute Of Life Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangyin Bengt I Samuelsson Institute Of Life Science Co Ltd filed Critical Jiangyin Bengt I Samuelsson Institute Of Life Science Co Ltd
Publication of AU2016309397A1 publication Critical patent/AU2016309397A1/en
Assigned to JIANGYIN BENGT I. SAMUELSSON INSTITUTE OF LIFE SCIENCE CO., LTD. reassignment JIANGYIN BENGT I. SAMUELSSON INSTITUTE OF LIFE SCIENCE CO., LTD. Amend patent request/document other than specification (104) Assignors: BENGT I. SAMUELSSON INSTITUTE OF LIFE SCIENCE RESEARCH
Application granted granted Critical
Publication of AU2016309397B2 publication Critical patent/AU2016309397B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
AU2016309397A 2015-08-14 2016-08-15 Mussel adhesive protein product and application thereof in inhibiting catarrh Active AU2016309397B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/CN2015/087011 WO2017028025A1 (zh) 2015-08-14 2015-08-14 贻贝粘蛋白产品及其抑制粘膜炎症的应用
AUPCT/CN2015/087011 2015-08-14
PCT/CN2016/095364 WO2017028777A1 (zh) 2015-08-14 2016-08-15 贻贝粘蛋白产品及其抑制粘膜炎症的应用

Publications (2)

Publication Number Publication Date
AU2016309397A1 AU2016309397A1 (en) 2018-03-01
AU2016309397B2 true AU2016309397B2 (en) 2020-10-22

Family

ID=58050454

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016309397A Active AU2016309397B2 (en) 2015-08-14 2016-08-15 Mussel adhesive protein product and application thereof in inhibiting catarrh

Country Status (12)

Country Link
US (2) US10485848B2 (enExample)
EP (1) EP3335739B1 (enExample)
JP (1) JP6816098B2 (enExample)
KR (1) KR102708321B1 (enExample)
CN (1) CN108348636B (enExample)
AU (1) AU2016309397B2 (enExample)
CA (1) CA2995549C (enExample)
DK (1) DK3335739T3 (enExample)
MA (1) MA42629A (enExample)
MX (1) MX2018000654A (enExample)
SG (1) SG11201800578YA (enExample)
WO (2) WO2017028025A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201800440SA (en) 2015-07-20 2018-02-27 Bengt I Samuelsson Institute Of Life Science Res Mussel adhesive protein product and applications thereof in suppression of skin inflammations
MX2018000335A (es) 2015-07-20 2018-05-22 Bengt I Samuelsson Institute Of Life Science Res Aplicaciones de los productos de la proteina adhesiva del mejillon para el tratamiento y la prevencion de enfermedades relacionadas con la melanina.
WO2017011986A1 (zh) 2015-07-20 2017-01-26 赵兵 一种空气过滤装置
WO2017028025A1 (zh) 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用
CN110139662B (zh) * 2017-07-05 2022-03-18 江阴贝瑞森制药有限公司 肽的抗炎用途
MA52794A (fr) * 2018-05-28 2021-04-14 Jiangyin Usun Pharmaceutical Co Ltd Nouvelle utilisation pharmaceutique
WO2020182139A1 (zh) * 2019-03-12 2020-09-17 杭州英健生物科技有限公司 消化道黏膜保护胶
EP4028409A4 (en) * 2019-09-14 2023-10-11 EnliTISA (Shanghai) Pharmaceutical Co., Ltd. NEW PEPTIDES
CN114929726A (zh) * 2019-12-02 2022-08-19 艾缇亚(上海)制药有限公司 新肽及其在炎症治疗中的用途
KR102596264B1 (ko) 2020-11-30 2023-11-01 주식회사 바이오빛 기능성 펩티드가 결합된 생체적합 폴리펩티드를 포함하는 염증 질환의 억제용 조성물
CN114588267A (zh) * 2020-12-04 2022-06-07 江苏恒瑞医药股份有限公司 一种含酰胺类局部麻醉药的药物组合物
CN112695064B (zh) * 2021-02-01 2023-06-16 大连海洋大学 从海洋腹足类黏液中提取的抗肝癌和抗肝纤维化的低聚肽
JP2022172889A (ja) * 2021-05-07 2022-11-17 大和製罐株式会社 吐出容器入り薬液
CN115778926A (zh) * 2023-01-30 2023-03-14 南京天纵易康生物科技股份有限公司 一种含贻贝粘蛋白的可降解唇部护理贴剂及其制备方法
CN118059215B (zh) * 2024-01-23 2024-08-30 海南美安生物医药科技有限公司 一种妇科温敏型原位凝胶及其制备和应用
WO2025195444A1 (en) 2024-03-20 2025-09-25 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New use of peptides derived from vasoactive intestinal peptide
CN118236471B (zh) * 2024-03-21 2025-08-19 湖南天根乐微君科技有限公司 一种用于改善鼻炎症状和鼻腔清洗的组合物及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103520766A (zh) * 2013-09-25 2014-01-22 高敏 贻贝粘蛋白液体产品、其制备方法及其应用
WO2014186937A1 (zh) * 2013-05-20 2014-11-27 Gao Min 贻贝粘蛋白凝胶的制备方法、贻贝粘蛋白凝胶及其应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
RU2043109C1 (ru) 1992-03-17 1995-09-10 Маина Александровна Бичурина Способ ингибиции вируса гриппа серотипов а и в
CN1112831A (zh) 1994-05-30 1995-12-06 乌力吉 含蜗牛提取液的长效多功能营养护肤水及其制法
NZ314867A (en) * 1997-05-21 1999-04-29 Mcfarlane Lab New Zealand Ltd Glucosamine and mussel extract compositions for use as anti-inflammatories
WO1999064580A1 (en) 1998-06-10 1999-12-16 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US20020018787A1 (en) 1999-05-21 2002-02-14 Roger V. Kendall Methods and compositions for modulating immune response and for the treatment of inflammatory disease
EP1408999B1 (en) 1999-07-21 2008-03-12 Bomac Research Limited Compositions addressing inflammation and/or degenerative disorders
WO2001012146A1 (en) 1999-08-16 2001-02-22 Playtex Products, Inc. Sunscreen lotion or spray composition
US7074433B2 (en) 2001-03-30 2006-07-11 Council Of Scientific And Industrial Research Process for the cure and control of Diabetes mellitus using natural products from Perna viridis
US6770302B2 (en) 2001-03-30 2004-08-03 Department Of Biotechnology Indian green mussel (Perna viridis) as a source of anti-HIV activity
US6905710B2 (en) 2001-08-31 2005-06-14 Council Of Scientific And Industrial Research Pharmaceutical composition useful for inhibition of osteoclast formation and a process for the extraction of mussel hudrolysate from indian green mussel
US20060275370A1 (en) * 2002-07-25 2006-12-07 Yih-Lin Chung Method and compositions for treatment of epithelial damage
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
CA2553775A1 (en) * 2004-01-20 2005-08-11 Richard F. Harty Compositions and methods of treatment for inflammatory diseases
CN101348520B (zh) 2007-12-14 2011-10-12 顾铭 一种使用混合吸附色谱分离纯化贻贝粘蛋白的方法
CN101348518B (zh) 2007-12-14 2011-09-28 顾铭 一种使用羧甲基离子交换色谱纯化贻贝粘蛋白的方法
KR101022884B1 (ko) * 2009-06-12 2011-03-16 주식회사 원바이오젠 약물층을 포함하는 폴리우레탄 폼 드레싱제 및 그 제조방법
CN101585874B (zh) 2009-06-30 2012-08-22 江阴贝瑞森生化技术有限公司 一种使用盐析和透析分离纯化贻贝粘蛋白的方法
JP2012526155A (ja) 2009-08-25 2012-10-25 ポステック アカデミー−インダストリー ファンデーション イガイ接着蛋白質またはその変異体に陰イオン性高分子が含まれたコアセルベート
KR101147847B1 (ko) 2010-06-02 2012-05-24 건국대학교 산학협력단 패류 유래 기능성 펩티드의 분리 정제 방법 및 기능성 펩티드의 용도
CN101991840B (zh) 2010-09-26 2012-09-05 浙江海洋学院 抗前列腺癌贻贝酶解提取物的制备方法及应用
KR101384746B1 (ko) * 2011-08-24 2014-04-14 포항공과대학교 산학협력단 홍합 접착 단백질을 이용한 다양한 기능성 생체분자의 표면 고정화
CN102302417B (zh) 2011-09-13 2012-12-26 佛山市安安美容保健品有限公司 一种含有海洋生物活性物质的全效防晒乳液
WO2013143077A1 (zh) * 2012-03-28 2013-10-03 江阴贝瑞森生化技术有限公司 使用多模式色谱纯化贻贝粘蛋白的方法
CN104323927A (zh) 2014-11-06 2015-02-04 济南星河康泰贸易有限公司 贻贝粘蛋白在制备皮肤美容化妆品上的应用
CN104645313A (zh) * 2015-01-28 2015-05-27 南京航空航天大学 一种修复止痒贻贝粘蛋白凝胶剂及其制备方法
CN104645320A (zh) 2015-01-28 2015-05-27 南京航空航天大学 一种创面修复用贻贝粘蛋白凝胶剂及其制备方法和应用
CN104857552B (zh) 2015-05-18 2018-08-10 赵明 一种止血贴及其制备方法
WO2017011986A1 (zh) 2015-07-20 2017-01-26 赵兵 一种空气过滤装置
SG11201800440SA (en) 2015-07-20 2018-02-27 Bengt I Samuelsson Institute Of Life Science Res Mussel adhesive protein product and applications thereof in suppression of skin inflammations
MX2018000335A (es) 2015-07-20 2018-05-22 Bengt I Samuelsson Institute Of Life Science Res Aplicaciones de los productos de la proteina adhesiva del mejillon para el tratamiento y la prevencion de enfermedades relacionadas con la melanina.
WO2017028025A1 (zh) 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014186937A1 (zh) * 2013-05-20 2014-11-27 Gao Min 贻贝粘蛋白凝胶的制备方法、贻贝粘蛋白凝胶及其应用
CN103520766A (zh) * 2013-09-25 2014-01-22 高敏 贻贝粘蛋白液体产品、其制备方法及其应用

Also Published As

Publication number Publication date
US11458190B2 (en) 2022-10-04
CN108348636B (zh) 2021-05-25
US20180243371A1 (en) 2018-08-30
JP6816098B2 (ja) 2021-01-20
SG11201800578YA (en) 2018-02-27
MA42629A (fr) 2018-06-20
WO2017028025A1 (zh) 2017-02-23
AU2016309397A1 (en) 2018-03-01
JP2019501108A (ja) 2019-01-17
US10485848B2 (en) 2019-11-26
KR102708321B1 (ko) 2024-09-23
DK3335739T3 (en) 2023-11-13
HK1257176A1 (en) 2019-10-18
CA2995549A1 (en) 2017-02-23
EP3335739B1 (en) 2023-10-04
CN108348636A (zh) 2018-07-31
EP3335739A4 (en) 2019-04-03
KR20180033517A (ko) 2018-04-03
US20200101135A1 (en) 2020-04-02
CA2995549C (en) 2024-01-02
MX2018000654A (es) 2018-07-06
WO2017028777A1 (zh) 2017-02-23
EP3335739A1 (en) 2018-06-20

Similar Documents

Publication Publication Date Title
US11458190B2 (en) Mussel adhesive protein product and use thereof for treating mucosal inflammation
RU2403012C2 (ru) Мукоадгезивные ксилоглюкансодержащие препараты, полезные в медицинских устройствах и в фармацевтических препаратах
CN108348577B (zh) 贻贝粘蛋白产品及其抑制皮肤炎症的应用
KR100290266B1 (ko) 크릴 효소의 신규 제약상 용도
EA011298B1 (ru) Применение бактерицидных пиримидинов для профилактики передачи вич половым путём и фармацевтические композиции на их основе
CN105148253A (zh) 皮肤粘膜抗菌组合物
TW200846015A (en) Agent for treating infectious skin disease and mucosal disease
EA016576B1 (ru) Применение сложных эфиров гидроксибензойной кислоты для получения лекарственного средства для предупреждения и лечения папилломавирусной инфекции человека
ES2811365T3 (es) Macrogols para aplicación a la mucosa, y sus usos terapéuticos
HK1257176B (en) Mussel adhesive protein product and the use thereof for the treatment of inflammation of the mucosa
US9693969B2 (en) Mucous membrane active agent application
JP6091699B2 (ja) 哺乳動物における腟弛緩症又は腟乾燥症を治療するのに用いられる医薬の製造における塩と糖との混合物の使用
RU2221562C1 (ru) Лекарственное средство и способ лечения генитального остроконечного кондиломатоза
EP1884241B1 (en) A oral preparation comprising dyclonine hydrochloride
CN106798916A (zh) 一种治疗hpv感染的组合物及其应用
CN100998576A (zh) 黄芩甙锌药物制剂
WO2017028775A1 (zh) 贻贝粘蛋白用于粘膜的防护
JP4632644B2 (ja) リポポリサッカライドを有効成分とする肛門圧低下外用剤
Chakrabarti Fungal diseases of the ear, nose, and throat
Involution et al. Progress of 3 l edical Science.
Stevens A Manual of the Practice of Medicine: Prepared Especially for Students
Rhodes Diseases of children
Keyes et al. Venereal Diseases: Their Complications and Sequelae
Butler-Smythe Notes on a Case of Profuse Hydroperitoneum Complicating Uterine Fibroids
HK1113747B (en) Use of hydroxybenzoic acid ester compounds for the manufacture of a medicament for the prevention and treatment of hpv infection

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: JIANGYIN BENGT I. SAMUELSSON INSTITUTE OF LIFE SCI

Free format text: FORMER NAME(S): BENGT I. SAMUELSSON INSTITUTE OF LIFE SCIENCE RESEARCH

FGA Letters patent sealed or granted (standard patent)